(MREO) |
| 0 (0%) 10-10 14:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.48 |
| Resistance 1: | 2.13 |
| Pivot price: | 1.96 |
| Support 1: | 1.87 |
| Support 2: | 1.71 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -44010000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 950.8 |
| Return on Equity (ttm) | -35.1 |
Company news
Fri, 10 Oct 2025
Weiss Ratings Reiterates Sell (D-) Rating for Mereo BioPharma Group (NASDAQ:MREO) - MarketBeat
Mon, 06 Oct 2025
CORRECTION - Verde AgriTech Announces District Scale - GlobeNewswire
Sat, 27 Sep 2025
Here's Why We're Not At All Concerned With Mereo BioPharma Group's (NASDAQ:MREO) Cash Burn Situation - Sahm
Tue, 19 Aug 2025
First Potential Treatment for 1-in-20,000 Bone Disease: āshibio Advances Novel Antibody Therapy - Stock Titan
Mon, 11 Aug 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO - PR Newswire
Mon, 11 Aug 2025
Mereo BioPharma Group (MREO) Announced Progress in the Phase 3 Orbit Study Testing UX143 - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
